Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial

Clinical trial NCT06668389 · RECRUITING

Trial details

NCT number: NCT06668389
Sponsor: The University of Hong Kong
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Congenital Heart Disease Repaired Tetralogy of Fallot (rTOF)Pulmonary Regurgitation Sodium-glucose Cotransporter 2 (SGLT2) Inhibitor Dapagliflozin (Forxiga)

Start date: 2025-05-12
Primary completion: 2026-12-31
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.